世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米の高度創傷治療市場規模、シェア、動向分析レポート:製品別(湿潤、抗菌)、用途別(慢性創傷、急性創傷)、最終用途別(病院、専門クリニック)、セグメント別予測、2024年~2030年


North America Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use (Hospitals, Specialty Clinics), And Segment Forecasts, 2024 - 2030

北米先進創傷治療市場の成長と動向 Grand View Research, Inc.の最新レポートによると、北米の高度創傷治療市場規模は、2024年から2030年にかけて年平均成長率4.79%を記録し、2030年には67億米ドルに達すると... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年12月1日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
90 英語

1~3営業日


 

サマリー

北米先進創傷治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、北米の高度創傷治療市場規模は、2024年から2030年にかけて年平均成長率4.79%を記録し、2030年には67億米ドルに達すると予測されている。高齢化社会の進展や糖尿病患者の増加が、同市場の成長を促す主な要因となっている。例えば、United Health Foundationの報告書(2023年5月発行)によると、米国には65歳以上の成人が5,580万人以上居住しており、2021年には米国人口の約16.8%を占めている。

外科手術の件数や外傷性の事故が増加している。例えば、2023年8月に発行されたiData Research社のレポートによると、米国では年間90万件以上の心臓手術が行われており、2029年には130万件に達すると予測されている。同様に、手術部位感染症も増加している。高度創傷ケア製品は、こうした手術部位感染を減らすのに役立つ。手術部位感染の増加は、予測期間中の市場成長を促進すると予想される。

また、多くの大手メーカーが新製品を投入しており、予測期間中に高度創傷ケア製品の需要増を生かすことができる可能性がある。例えば、2022年9月、PolyNovo Limited Companyは、自社製品「NovoSorb MTX」のFDA 510(k)クリアランスを取得した。この製品は、複雑な慢性創傷の管理に使用される予定である。このように、上記の要因が市場の成長を後押ししている。

北米先進創傷治療市場レポートハイライト

- 製品別では、慢性創傷患者の増加により、湿潤創傷ケア分野が2023年の市場を独占

- 用途別では、糖尿病性足潰瘍の増加により、急性創傷分野が予測期間中に市場を支配する可能性が高い

- 最終用途別では、入院患者の手術件数が増加していることから、病院分野が先進創傷治療市場を支配している。一方、在宅医療分野は予測期間中にCAGRが最も速く成長すると予測されている。

- 米国が2023年に最も高い収益シェアを占め、市場を支配した。



ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. North America Advanced Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.1.5. Increasing number of surgeries
3.2.2. Market restraint analysis
3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
3.2.2.2. Stringent regulations for manufacturing of wound care products
3.3. North America Advanced Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. North America Advanced Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Moist
4.1.2. Antimicrobial
4.1.3. Active
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. North America Advanced Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Moist wound care
4.5.1.1. Moist market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Antimicrobial
4.5.2.1. Antimicrobial market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Silver
4.5.2.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Non-silver
4.5.2.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Active
4.5.3.1. Active market estimates and forecast 2018 to 2030s, (USD Million)
4.5.3.2. Biomaterials
4.5.3.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Skin-substitute
4.5.3.3.1. Skin-substitute market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. North America Advanced Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. North America Advanced Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Chronic Wounds
5.5.1.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.2. Diabetic foot ulcers
5.5.1.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.3. Pressure ulcers
5.5.1.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.4. Venous leg ulcers
5.5.1.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.5. Others chronic wounds
5.5.1.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Acute Wounds
5.5.2.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.2. Surgical & traumatic wounds
5.5.2.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.3. Burns
5.5.2.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. North America Advanced Wound Care Devices: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Specialty clinics
6.1.3. Home healthcare
6.1.4. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. North America Advanced Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Home healthcare
6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. North America Advanced Wound Care Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2023
7.4.1. North America
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
7.7.2 U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018-2030
7.7.3 Canada
7.6.3.6. Key country dynamics
7.6.3.7. Competitive scenario
7.6.3.8. Regulatory framework
7.6.3.9. Reimbursement scenario
7.6.3.10. Canada market estimates and forecasts, 2018-2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Smith & Nephew PLC
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Mölnlycke Health Care AB
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. ConvaTec Group PLC
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Baxter International
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. URGO Medical
8.3.8.1. Financial performance
8.3.8.2. Product benchmarking
8.3.8.3. Strategic initiatives
8.3.9. Coloplast Corp.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Medtronic
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. 3M
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Derma Sciences (Integra LifeSciences)
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Medline Industries, Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

North America Advanced Wound Care Market Growth & Trends

The North America advanced wound care market size is anticipated to reach USD 6.7 billion by 2030, registering a CAGR of 4.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth in the aging population as well as increasing figure of diabetic patients are some major factors driving this market's growth. For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing number of senior populations is anticipated to propel the market growth during the forecast period.

There has been a growth in the number of surgical procedures and traumatic incidents. For instance, per iData Research's report, published in August 2023, more than 900,000 cardiac surgery procedures are performed in the U.S. annually, which is expected to reach 1.3 million by 2029. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help reduce these surgical site infections. An increase in the number of surgical site infections is expected to drive the market growth over the forecast period.

In addition, many leading manufacturers are introducing new products, which may help them capitalize on the increasing demand for advanced wound care products during the forecast period. For instance, in September 2022, PolyNovo Limited Company received FDA 510 (k) clearance for its product 'NovoSorb MTX'. This product is intended to be used to manage complex chronic wounds. Thus, the above-mentioned factors are boosting market growth.

North America Advanced Wound Care Market Report Highlights

• Based on product, the moist wound care segment dominated the market in 2023, owing to an increase in number of chronic wound patients

• Based on application, the acute wound segment is likely to dominate the market in the forecast period, owing to an increase in number of diabetic foot ulcers

• Based on the end-use, the hospital segment dominated the advanced wound care market, owing to an increasing number of surgeries among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth of CAGR over the forecast period

• U.S. dominated the market with the highest revenue share in 2023, owing to the increasing number of surgical procedures and technological advancements



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. North America Advanced Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.1.5. Increasing number of surgeries
3.2.2. Market restraint analysis
3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
3.2.2.2. Stringent regulations for manufacturing of wound care products
3.3. North America Advanced Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. North America Advanced Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Moist
4.1.2. Antimicrobial
4.1.3. Active
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. North America Advanced Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Moist wound care
4.5.1.1. Moist market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Antimicrobial
4.5.2.1. Antimicrobial market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Silver
4.5.2.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Non-silver
4.5.2.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Active
4.5.3.1. Active market estimates and forecast 2018 to 2030s, (USD Million)
4.5.3.2. Biomaterials
4.5.3.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Skin-substitute
4.5.3.3.1. Skin-substitute market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. North America Advanced Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. North America Advanced Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Chronic Wounds
5.5.1.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.2. Diabetic foot ulcers
5.5.1.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.3. Pressure ulcers
5.5.1.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.4. Venous leg ulcers
5.5.1.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.5. Others chronic wounds
5.5.1.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Acute Wounds
5.5.2.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.2. Surgical & traumatic wounds
5.5.2.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.3. Burns
5.5.2.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. North America Advanced Wound Care Devices: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Specialty clinics
6.1.3. Home healthcare
6.1.4. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. North America Advanced Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Home healthcare
6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. North America Advanced Wound Care Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2023
7.4.1. North America
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
7.7.2 U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018-2030
7.7.3 Canada
7.6.3.6. Key country dynamics
7.6.3.7. Competitive scenario
7.6.3.8. Regulatory framework
7.6.3.9. Reimbursement scenario
7.6.3.10. Canada market estimates and forecasts, 2018-2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Smith & Nephew PLC
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Mölnlycke Health Care AB
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. ConvaTec Group PLC
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Baxter International
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. URGO Medical
8.3.8.1. Financial performance
8.3.8.2. Product benchmarking
8.3.8.3. Strategic initiatives
8.3.9. Coloplast Corp.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Medtronic
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. 3M
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Derma Sciences (Integra LifeSciences)
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Medline Industries, Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(advanced wound)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18 10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る